EMV Capital (Acquired) Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Professionals
  • 13

Professionals

  • Investments
  • 25

  • Exits
  • 19

Exits

EMV Capital (Acquired) General Information

Company Description

Founded in 2018, EMV Capital was a venture capital firm based in London, United Kingdom. The firm sought to invest in early-stage, high-growth deep tech companies in the UK's life science, sustainability, and industrial sectors and internationally. On August 25, 2020, the firm was acquired by EMV Capital.

Business Details

Year Founded
2018
Investor Status
Acquired/Merged
Trade Association
British Venture Capital Association (BRVCA)
Primary Investor Type
Venture Capital
Corporate Office
  • 2nd Floor, 25-28 Old Burlington Street
  • London W1S 3AN
  • England, United Kingdom

EMV Capital (Acquired) Investments & Acquisitions (25)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
AMR Bio 29-Sep-2025 Early Stage VC Drug Delivery Pre-Clinical Trials
ProAxsis 07-Jul-2025 Diagnostic Equipment Generating Revenue
Martlet Capital 13-May-2024 Private Equity Generating Revenue
Glycotest 23-Jan-2024 Biotechnology Generating Revenue
QuantalX 01-Jan-2024 Diagnostic Equipment Generating Revenue
Ventive (Building Products) 06-Nov-2023 Building Products Generating Revenue
DName-iT 30-Jun-2023 Laboratory Services (Healthcare) Generating Revenue
EpiBone 27-Dec-2022 Biotechnology Clinical Trials - Phase 2
Fox biosystems 13-Dec-2022 Later Stage VC Other Devices and Supplies Bankruptcy: Liquidation
Ventive (Building Products) 20-Oct-2022 Later Stage VC Building Products Generating Revenue
You’re viewing 10 of 25 investments and acquisitions. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EMV Capital (Acquired) Exits (19)

Company Name Exit Date Exit Type Exit Size
Sofant Technologies 04-Jul-2026 Later Stage VC
EpiBone 24-Oct-2025
Fox biosystems 01-Jan-2025
SageTech Medical 06-Dec-2024
Bimaplan 23-Oct-2023
G-Tech Medical 10-Jul-2023
Autorose 04-Aug-2022
Insight (Electronic Equipment and Instruments) 01-Dec-2021
Nanotech Industrial Solutions 01-Dec-2021 Later Stage VC
Recycling Technologies 01-Dec-2021 IPO
You’re viewing 10 of 19 exits. Get the full list »

EMV Capital (Acquired) Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

EMV Capital (Acquired) Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Martlet Capital Cambridge, United Kingdom 2011

EMV Capital (Acquired) FAQs

  • What is EMV Capital (Acquired)?

    Founded in 2018, EMV Capital was a venture capital firm based in London, United Kingdom.

  • When was EMV Capital (Acquired) founded?

    EMV Capital (Acquired) was founded in 2018.

  • Where is EMV Capital (Acquired) headquartered?

    EMV Capital (Acquired) is headquartered in London, United Kingdom.

  • How many investments has EMV Capital (Acquired) made?

    EMV Capital (Acquired) has made 25 investments.

  • What has EMV Capital (Acquired) invested in?

    EMV Capital (Acquired) has made numerous investments in companies like AMR Bio, ProAxsis, and Martlet Capital within the Drug Delivery, Diagnostic Equipment, and Private Equity industries.

  • What has EMV Capital (Acquired) invested in recently?

    EMV Capital (Acquired)'s latest investment was on 29-Sep-2025 in AMR Bio, a company within the Drug Delivery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process